Fundraising FoxSeraph Biosciences
Detroit, US · Founded 2016 · Delaware corporation
Find your way into Seraph Biosciences
Sign up to see every warm intro you have to Seraph Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Seraph Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
MC
Matthew CullenBoard director
JM
JAMES MAULTBoard director
Reported raises · per SEC filings
Form D private placements$10M disclosed across 3 rounds · 2017–2018
▶$7MraisedAug 2021 · 29 investors · BiotechnologyRule 506(b)
▶$7MraisedAug 2021 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary LovemanDirector
- Ahmad Nadeem IshaqueDirector
- Charles ShanleyDirector
- Scott MerzDirector
- James ShanleyExecutive Officer
- Michael ShieldsDirector
- Richard CreagerDirector
- Braden RobisonExecutive Officer
- Offering amount
- $7.2M
- Amount sold
- $7M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.5MraisedJan 2019 · 15 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJan 2019 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul GlantzDirector
- Michael ShieldsDirector
- James ShanleyExecutive Officer
- Charles ShanleyDirector
- Matthew CullenDirector
- Scott MerzDirector
- Braden RobisonExecutive Officer
- Gregory AunerExecutive Officer, Director
- Offering amount
- $4.2M
- Amount sold
- $1.5M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.5MraisedFeb 2017 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedFeb 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MARK TREXLERExecutive Officer
- JAMES MAULTDirector
- Matthew CullenDirector
- Charles ShanleyExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.5M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Seraph Biosciences raised?
- Seraph Biosciences has disclosed $10M raised across 3 rounds.
- Where is Seraph Biosciences headquartered?
- Seraph Biosciences is headquartered in Detroit, US.